Skip to content

Study on the relevance of positive patch test reactions to ylang ylang oil

Study on the relevance of positive patch test reactions to ylang ylang oil - ylang ylang oil study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00035786
Enrollment
50
Registered
2024-12-20
Start date
2025-01-06
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

L23

Interventions

Group 1: patients with contact sensitization to ylang ylang oil Patients with sensitization to ylang ylang oil are recruited retrospectively from the IVDK database. They apply two body care oils (posi
further appointments may also be necessary.

Sponsors

Informationsverbund Dermatologischer Kliniken (IVDK)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: positive patch test reaction to ylang ylang oil 10% pet.

Exclusion criteria

Exclusion criteria: - Dermatitis or previous skin damage in the designated test areas - Severe or generalized dermatitis - local treatment with corticosteroids or UV exposure in the intended test area - Current or recent systemic immunosuppression - Pregnancy and breastfeeding

Design outcomes

Primary

MeasureTime frame
Frequency of allergic reactions to care products containing ylang ylang oil. The measurement is carried out continuously over a period of 28 days. A positive reaction is indicated by redness with a palpable infiltrate, possibly also with (confluent) vesicles at the application site.

Secondary

MeasureTime frame
Frequency of reproducible patch test reactions to ylang ylang oil 10% pet. according to criteria of the German Contact Allergy Research Group (DKG) at the day 3 reading (72h after application).

Countries

Austria, Germany, Switzerland

Contacts

Public ContactSteffen Schubert

Informationsverbund Dermatologischer Kliniken (IVDK)

sschube4@gwdg.de+49 551 505 39 622

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026